Month: May 2020

RICHMOND, Va., May 07, 2020 (GLOBE NEWSWIRE) — The board of directors of The Brink’s Company (NYSE:BCO) today declared a regular quarterly dividend of 15 cents per share on the company’s common stock. The dividend is payable on June 1, 2020, to shareholders of record on May 18, 2020.About The Brink’s CompanyThe Brink’s Company (NYSE:BCO) is the global leader in total cash management, route-based secure logistics and payment solutions including cash-in-transit, ATM services, cash management services (including vault outsourcing, money processing and intelligent safe services), and international transportation of valuables. Our customers include financial institutions, retailers, government agencies, mints, jewelers and other commercial operations.  Our global network of operations in 47 countries serves customers in more than 100...

VANCOUVER, British Columbia, May 07, 2020 (GLOBE NEWSWIRE) — Azucar Minerals Ltd. (“Azucar” or the “Company”) (TSX-V: AMZ; OTCQX: AXDDF) announces that, pursuant to its Stock Option Plan, it has granted stock options to certain directors, employees and consultants of the Company to purchase an aggregate 425,000 common shares in the capital of the Company at an exercise price of $0.11 per share which expire on May 9, 2022.About AzucarAzucar is an exploration company with a mandate to thoroughly explore the El Cobre project in Veracruz, Mexico, a ~7,000 Ha property which covers multiple gold-rich porphyry targets, as demonstrated by recent drilling. Azucar holds a 100% interest in the El Cobre project, subject to net smelter returns royalty interests, assuming production from the property exceeds 10,001 tonnes...

CALGARY, Alberta, May 07, 2020 (GLOBE NEWSWIRE) — Baytex Energy Corp. (“Baytex”) (TSX, NYSE: BTE) reports that all matters presented for approval at the annual meeting of shareholders held today were approved.  A total of 197,784,694 common shares being 35.29% of Baytex’s issued and outstanding shares were represented at the meeting.At the meeting, all of the nominees proposed as directors were duly elected. Results of the vote are set out below.KPMG LLP was appointed as Baytex’s auditor until the next annual meeting of shareholders, and the directors were authorized to fix their remuneration. The result of the vote is as follows.In addition, a non-binding advisory resolution with respect to Baytex’s approach to executive compensation was approved.  The result of the vote is as follows.Baytex Energy Corp. is an oil and gas corporation...

CALGARY, Alberta, May 07, 2020 (GLOBE NEWSWIRE) — Maxim Power Corp. (“MAXIM” or the “Corporation”) (TSX: MXG) announced today the release of financial and operating results for the first quarter ended March 31, 2020. The unaudited condensed consolidated interim financial statements, accompanying notes and Management’s Discussion and Analysis (“MD&A”) will be available on SEDAR and on MAXIM’s website on May 7, 2020. All figures reported herein are Canadian dollars unless otherwise stated.OPERATING RESULTSAdjusted EBITDA and net income increased in the first quarter of 2020 when compared to 2019, primarily due to realizing power prices of $171.45 per MWh in 2020, as compared to $67.29 per MWh in 2019, fuel and carbon tax savings as a result of lower generation volumes, lower operations and maintenance...

NEW YORK, May 07, 2020 (GLOBE NEWSWIRE) — In a release under the same headline issued earlier today by Apollo Commercial Real Estate Finance, Inc. (NYSE:ARI), please note that in the fifth paragraph, the time of the earnings teleconference call has been corrected to 9:00 a.m. on Friday, May 8, 2020, not 10:00 a.m. as previously stated. The corrected release follows:Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI), today reported results for the quarter ended March 31, 2020. First quarter 2020 net loss per share of common stock was $0.86 and Operating Earnings (a non-GAAP financial measure defined below) per share of common stock was $0.40. “I am extremely proud of the hard work, perseverance and dedication of the team at our Manager, ACREFI Management, LLC, an indirect subsidiary of Apollo Global Management,...

VANCOUVER, British Columbia, May 07, 2020 (GLOBE NEWSWIRE) — Almadex Minerals Ltd. (“Almadex” or the “Company”) (TSX-V: DEX) announces that, pursuant to its Stock Option Plan, it has granted stock options to certain directors, employees, and consultants of the Company to purchase an aggregate 425,000 common shares in the capital of the Company at an exercise price of $0.19 per share which expire on May 9, 2022.About AlmadexAlmadex Minerals Ltd. is an exploration company that holds a large mineral portfolio consisting of projects and NSR royalties in Canada, the U.S., and Mexico. This portfolio is the direct result of over 35 years of prospecting and deal-making by Almadex’s management team. Almadex owns a number of portable diamond drill rigs, enabling it to conduct cost effective first pass exploration...

HC2 Recommends Stockholders Sign, Date and Promptly Return the WHITE Consent Revocation Card and Mark “REVOKE MY CONSENT” Boxes to Oppose Each of Percy Rockdale’s Proposals and Support HC2’s Independent, Experienced and Highly-Qualified DirectorsHC2 Advises Stockholders to Vote For HC2’s Full Slate of Directors at HC2’s 2020 Annual Meeting of StockholdersNEW YORK, May 07, 2020 (GLOBE NEWSWIRE) — HC2 Holdings, Inc. (“HC2” or the “Company”) (NYSE: HCHC), a diversified holding company, today reminded stockholders to review HC2’s extensive board refreshment, stockholder engagement and voluntary compensation reductions, before making a considered judgment on Board composition at the Company’s 2020 Annual Meeting of Stockholders (the “2020 Annual Meeting”). The Company strongly advises that stockholders refrain from committing to a hasty...

VANCOUVER, Washington and WINSTON-SALEM, N.C., May 07, 2020 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that Novant Health is initiating patient enrollment in CytoDyn’s Phase 2b/3 trial for severely and critically ill COVID-19 patients.Leronlimab has been administered to 54 severely and critically ill COVID-19 patients thus far under Emergency Investigational New Drug (EINDs) authorizations granted by the U.S. Food and Drug Administration (FDA).  Preliminary results from this patient population led to the FDA’s recent clearance for CytoDyn’s Phase 2b/3 clinical trial for 390 patients, which is randomized, placebo-controlled with 2:1...

SHANGHAI, China, May 07, 2020 (GLOBE NEWSWIRE) — Junshi Biosciences (HKEX: 1877) a leading innovation-driven biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies, today announced that the China National Medical Products Administration (NMPA) has accepted a supplemental New Drug Application (sNDA) for toripalimab as a 2nd line treatment for patients with locally advanced or metastatic urothelial carcinoma who have received systemic therapy.Urothelial carcinoma is the most common (more than 90%) histologic type of bladder cancer in China. Bladder cancer incidence is estimated to be 80,000 cases per year in the country. It ranked ninth for all cancer deaths in China, accounting for about 14% of bladder cancer deaths worldwide.The sNDA is based on the results of POLARIS-03 study...